IE
CGEM icon

Israel Englander’s Cullinan Oncology CGEM Stock Holding History

Israel Englander’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Sell
346,232
-350
-0.1% -$5.2K ﹤0.01% 2773
2026
Q1 		$4.92M Sell
346,582
-15,913
-4% -$205K ﹤0.01% 2962
2025
Q4 		$3.75M Sell
362,495
-187,976
-34% -$1.7M ﹤0.01% 3325
2025
Q3 		$3.26M Buy
550,471
+39,643
+8% +$290K ﹤0.01% 3565
2025
Q2 		$3.85M Sell
510,828
-272,349
-35% -$2.19M ﹤0.01% 3254
2025
Q1 		$5.93M Sell
783,177
-50,785
-6% -$487K ﹤0.01% 2695
2024
Q4 		$10.2M Buy
833,962
+45,395
+6% +$653K 0.01% 2167
2024
Q3 		$13.2M Buy
+788,567
New +$14M 0.01% 1942
2024
Q1 		– Sell
-233,366
Closed -$2.38M – 6218
2023
Q4 		$2.38M Sell
233,366
-6,359
-3% -$56.3K ﹤0.01% 3470
2023
Q3 		$2.17M Buy
239,725
+50,652
+27% +$528K ﹤0.01% 3477
2023
Q2 		$2.03M Sell
189,073
-55,480
-23% -$589K ﹤0.01% 3466
2023
Q1 		$2.5M Buy
244,553
+30,284
+14% +$334K ﹤0.01% 3219
2022
Q4 		$2.26M Buy
214,269
+64,862
+43% +$788K ﹤0.01% 3469
2022
Q3 		$1.92M Sell
149,407
-172,277
-54% -$2.32M ﹤0.01% 3776
2022
Q2 		$4.12M Buy
321,684
+311,169
+2,959% +$3.53M ﹤0.01% 2995
2022
Q1 		$110K Buy
+10,515
New +$142K ﹤0.01% 6099
2021
Q4 		– Sell
-207,030
Closed -$4.67M – 6848
2021
Q3 		$4.67M Sell
207,030
-26,631
-11% -$712K ﹤0.01% 2944
2021
Q2 		$6.02M Sell
233,661
-170,175
-42% -$5.23M ﹤0.01% 2512
2021
Q1 		$16.8M Buy
+403,836
New +$16.4M 0.01% 1240

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Israel Englander's CGEM Position: Q2 2026 in Review

Israel Englander reduced its Cullinan Oncology (CGEM) stake by 0.1% in Q2 2026, selling an estimated $5.2K and leaving 346,232 shares worth $6.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Israel Englander first reported a position in CGEM in Q1 2021 and has held it in 19 quarters since. The position peaked at $16.8M in Q1 2021. 182 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Israel Englander held 346,232 shares of Cullinan Oncology worth $6.3M as of Q2 2026.
  • Israel Englander sold 350 Cullinan Oncology shares in Q2 2026, an estimated $5.2K.
  • Cullinan Oncology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2773 holding.
  • Israel Englander first reported a position in Cullinan Oncology in Q1 2021 and has held it in 19 quarters since.
  • Israel Englander's Cullinan Oncology position peaked at $16.8M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.